Xvivo Perfusion AB (publ) (LON:0RKL)

Market Cap	558.00M -40.5%
Revenue (ttm)	65.47M -1.2%
Net Income	2.03M -85.4%
EPS	0.06 -85.3%
Shares Out	n/a
PE Ratio	275.10
Forward PE	55.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,084
Average Volume	3,212
Open	225.20
Previous Close	226.00
Day's Range	220.80 - 225.20
52-Week Range	160.80 - 333.73
Beta	1.81
RSI	70.54
Earnings Date	Apr 24, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1998
• Employees: 198
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RKL

Financial Performance

In 2025, Xvivo Perfusion AB's revenue was 812.17 million, a decrease of -1.25% compared to the previous year's 822.42 million. Earnings were 25.16 million, a decrease of -85.39%.

Financial numbers in SEK